GE HealthCare Unveils AI-Powered CareIntellect App for Oncology, Promising to Streamline Patient Care

GE HealthCare Announces CareIntellect App for Oncology With AI-Powered Insights for Clinicians

Data Integration: Combines structured and unstructured data for a holistic patient view. GE HealthCare announced CareIntellect for Oncology, a new cloud-first application that integrates multi-modal patient data from disparate systems into a single view, utilising generative AI to summarise clinical notes and reports. Set to launch in the US in 2025, this application aims to transform how healthcare providers access and utilise patient information. Also Read: Microsoft Announces New AI Models and Solutions for Healthcare Initially, the application will focus on prostate and breast cancer. It organises structured and unstructured data (e.g., medical images, medical records, notes, and device readings), summarises complex medical histories, supports treatment response assessments, aids in assessing clinical trial eligibility, and tracks adherence to treatment protocols in an easy-to-navigate view, GE HealthCare said on Monday. According to the official release, Tampa General Hospital and UT Southwestern Medical Center will serve as early evaluators of CareIntellect for Oncology, and integration is already underway. Also Read: Suki Secures USD 70 Million to Expand AI Healthcare Solutions The company says CareIntellect for Oncology is the first application available as part of GE HealthCare's new CareIntellect family of clinical and operational applications designed to help healthcare providers quickly and easily implement new applications without the need for a costly and time-consuming product-by-product integration approach. Dr Taha Kass-Hout, Global Chief Science and Technology Officer at GE HealthCare, said, "CareIntellect is designed to help providers streamline access to critical patient information and surface key changes since the patient's last visit. By ensuring the provider has the right information at their fingertips, they can spend less time sifting through information and more time helping patients." Dr Peter Chang, Senior Vice President, Chief Transformation Officer at Tampa General Hospital added: "We were impressed by how quickly GE HealthCare was able to design the application to include breast cancer in a matter of weeks. We look forward to putting this in the hands of our care teams and using the AI-enabled functionality to help clinicians spend time where it matters most -- delivering outstanding patient care." Also Read: Affineon Health Launches AI Platform to Streamline Healthcare Admin Tasks The application is planned to be widely available to US customers in 2025, with additional future expansion intended for Canada, the UK, and Ireland.

GE HealthCare announces time-saving AI tool for doctors who treat cancer

CareIntellect for Oncology can also help identify relevant clinical trials that patients might be eligible for, saving oncologists hours of work, said Chelsea Vane, vice president of digital products at GE HealthCare. That process has traditionally required doctors to scroll through a database of available trials, memorize inclusion and exclusion criteria and dig through patient records to determine a good fit, Vane told CNBC. "What we've done is remove that," she said. The purpose of the new app is to save oncologists time and effort, but if doctors want to dive into more detail, CareIntellect for Oncology allows them to view the original record that's referenced, the company said. GE HealthCare is planning to make CareIntellect for Oncology widely available to U.S. customers in 2025, and it will initially be optimized for prostate and breast cancers. Health organizations such as Tampa General Hospital are already evaluating it, the company said. Since the tool is cloud-based, it will drive recurring revenue for GE HealthCare, Kass-Hout said. The company is planning to introduce additional apps under the CareIntellect brand in the future, Kass-Hout said. The oncology tool is the first offering, and health-care organizations will be able to easily pick and choose the apps that they want to enable, he added. GE HealthCare is also hoping to integrate its CareIntellect products with some of the other early stage AI initiatives it teased on Monday. The company highlighted five new AI products that it is developing, including a collaborative team of AI agents, a tool to predict an aggressive type of breast cancer recurrence, and a tool to flag suspicious mammography scans to radiologists more quickly. GE HealthCare decided to preview the new tools to give customers an idea of the problems it's trying to solve, Kass-Hout said. The company will solicit feedback from health-care organizations and work with regulators as necessary, he said. For instance, GE HealthCare is exploring how a group of AI agents can work together as a team to support doctors through its tool called Health Companion. The agents in Health Companion will be trained as experts in specific domains, such as radiology, pathology or genomics, and offer insights based on their expertise, Kass-Hout said. The agents could identify whether a specific symptom is a side effect of treatment or a sign of disease progression, for example, and suggest next steps, he added. Ideally, the tool will give doctors the same kind of support they'd expect from working with a multidisciplinary team, Kass-Hout said. But while consulting a panel of experts can take days or weeks, Health Companion would be available immediately. "At the moment, it's an early concept," he said. "Our aim is to elevate the standard of care and get ahead of the overburden of clinicians trying to take care of their patient."